2nd International Conference on Prostate Cancer and Therapeutics

2nd International Conference on Prostate Cancer and Therapeutics
Date: August 22-23, 2016
Venue: Philadelphia, Pennsylvania, USA
Prostate Cancer 2016

Online PR News – 11-March-2016 – Philadelphia, Pennsylvania, USA – Recommended Prostate Cancer Conferences |Cancer Conferences |Oncology Conferences | Cancer Science Conference |Cancer Therapy Conferences |Urology Conferences
Conference Series LLC is overwhelmed to announce the commencement of its second consecutive Prostate Cancer Conference.

2nd International Conference on Prostate Cancer and Therapeutics
Date: August 22-23, 2016
Venue: Philadelphia, Pennsylvania, USA

Prostate Cancer 2016 will be organized around the theme “Encompassing the Possibilities and Novel Targets in Prostate Cancer Research”

Prostate Cancer conference throws light on thought provoking topics and recent research in the field of Prostate cancer like, Future Perspectives on Prostate Cancer, Benign Prostatic Hyperplasia Treatments for Castration Resistant Prostate Cancer, Translational Research and Pathology Screening and early diagnosis of prostate cancer, Prostatitis, Radical Prostatectomy, Clinical Trials on Prostate Cancer, Prostate Cancer Side Effects and Management, State-of-the art: vision on the future, and many more.

Estimated deaths and new cases in United States in 2014 are about 29,480 men will die of prostate cancer and about 233,000 new cases of prostate cancer will be diagnosed. Prostate cancer continues to be a topic of great debate across the world, both in medical circles and of course for the many men diagnosed. Prostate Cancer 2016 supports the thousands of men facing prostate cancer every year.
Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. About 1 man in 38 will die of prostate cancer. Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 2.9 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today. Prostate cancer occurs mainly in older men. About 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66.

Prostate cancer conferences are organized by Conference Series LLC which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. Hematology 2016 will provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.
For more details visit our website: http://prostatecancer.cancersummit.org/

Unique Features:
• Our robust on-line publicity attracts 20000 users and 60000 views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences.
• The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows
Accepted Abstracts will be published in PubMed, MEDLINE, Pro Quest, SCOPUS, SOCOLAR, EBSCO, CAS, Hinari, Index Copernicus, Google Scholar, SCIRUS, DOAJ indexed journals
Certain benefits that you will avail as a Speaker:
 International Exposure to research work
 Abstract will be viewed by 30,000-40,000 viewers every year
 Live streaming of talk
 International speaker certificate
 Research work will be published in International Journals without any additional charges
 Networking and Collaborating opportunity with peer researchers

Conference mainly emphasizes on:
With members from around the world focused on learning about prostate cancer and its advances; this is your best opportunity to reach the largest assemblage of participants from the prostate cancer research community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in prostate cancer are hallmarks of this conference.

Target Audience:
• Medical oncologists
• Radiation oncologists
• Surgeons
• Urologists
• Fellows
• Nurse practitioners and Nurses
• Physician assistants
• Pharmacists
• Health care professionals
• Business Entrepreneurs
• Prostate Cancer Associations and Societies